Novartis in $1.68B Blood Unit Deal With Grifols

Nov. 11 (Bloomberg) -- Bloomberg’s Ryan Chilcote reports that Novartis has agreed to sell a blood transfusion diagnostics unit to Grifols for $1.68 billion in the company’s biggest asset sale in five years. He speaks on Bloomberg Television’s “The Pulse.”

Sales Check With Hudson's Bay CEO Jerry Storch
31:31 - Hudson's Bay CEO Jerry Storch weighs in on Black Friday sales. He speaks on "Bloomberg Markets." (Source: Bloomberg)
  • Black Friday Retail Sales: The Winners & the Losers
  • Battle of the Charts: Retail Traffic, Euro Versus Dollar
  • 2016 Will Be a Better Year for Stocks, Here's Why